Whole-Body 18 F-FDG PET/CT Patlak Parametric Imaging of Hepatic Alveolar Echinococcosis.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
01 Dec 2023
Historique:
medline: 8 11 2023
pubmed: 6 10 2023
entrez: 6 10 2023
Statut: ppublish

Résumé

We present dynamic 18 F-FDG PET/CT acquisition in a 52-year-old old woman with histologically proven hepatic alveolar echinococcosis (AE). Metabolic rate of FDG images generated with traditional and relative Patlak analysis show the AE manifestation in the liver significantly better the static SUV images. Dynamic PET may thus have the potential to increase sensitivity in the assessment of hepatic AE manifestations. Such parametric images may offer complementary qualitative information and quantification superior to SUV images.

Identifiants

pubmed: 37801583
doi: 10.1097/RLU.0000000000004878
pii: 00003072-990000000-00741
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1089-1090

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: All the authors have no personal conflicts of interest to declare. The University Hospital Zurich holds a research agreement with GE Healthcare.

Références

Husmann L, Gruenig H, Reiner CS, et al. Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis. Sci Rep . 2022;12:11392.
Husmann L, Muehlematter UJ, Grimm F, et al. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis. Parasitol Int . 2021;83:102356.
Lotsch F, Waneck F, Groger M, et al. FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria. Trop Med Int Health . 2019;24:663–670.
Pernthaler B, Brcic L, Aigner RM, et al. 18 F-FDG PET/CT in primary mesothelioma of the liver. Clin Nucl Med . 2023;48:49–51.
Doroudinia A, Karam MB, Ghadimi N, et al. Steatotic hepatitis presenting as a huge hypermetabolic liver mass. Clin Nucl Med . 2022;47:e399–e400.
Winkens T, Rudakoff W, Rauchfuss F, et al. FDG PET/CT to detect incidental findings in patients with hepatocellular carcinoma-additional benefit for patients considered for liver transplantation? Clin Nucl Med . 2021;46:532–539.
Raad RA, Haddad L, Jabbour T, et al. Inflammatory myofibroblastic tumor of the liver mimicking metastasis on 18 F-FDG PET/CT. Clin Nucl Med . 2021;46:47–48.
Garcia-Burillo A, Monturiol-Duran JA, Iglesias-Felip C, et al. Follicular thyroid carcinoma metastases on round ligament of liver. Clin Nucl Med . 2021;46:326–328.
Filizoglu N, Oksuzoglu K, Ozguven S. Primary adenosquamous carcinoma of the liver on FDG PET/CT. Clin Nucl Med . 2021;46:e572–e573.
Chen Z, Xue Q, Yang Y, et al. 68 Ga-FAPI and 18 F-FDG PET/CT images of a patient with Rosai-Dorfman disease with liver involvement. Clin Nucl Med . 2022;47:1079–1081.
Zaker N, Kotasidis F, Garibotto V, et al. Assessment of lesion detectability in dynamic whole-body PET imaging using compartmental and Patlak parametric mapping. Clin Nucl Med . 2020;45:e221–e231.
Kaji T, Osanai K, Nakata T, et al. Dynamic whole-body 18 F-FDG PET for minimizing patient motion artifact. Clin Nucl Med . 2020;45:880–882.
Fiz F, Bini F, Gabriele E, et al. Role of dynamic parameters of 18 F-DOPA PET/CT in pediatric gliomas. Clin Nucl Med . 2022;47:517–524.
Besson FL, Fernandez B, Faure S, et al. Fully integrated quantitative multiparametric analysis of non-small cell lung cancer at 3-T PET/MRI: toward one-stop-shop tumor biological characterization at the supervoxel level. Clin Nucl Med . 2021;46:e440–e447.
Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab . 1983;3:1–7.
Zuo Y, Qi J, Wang G. Relative Patlak plot for dynamic PET parametric imaging without the need for early-time input function. Phys Med Biol . 2018;63:165004.
Karakatsanis NA, Lodge MA, Tahari AK, et al. Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application. Phys Med Biol . 2013;58:7391–7418.

Auteurs

Alexander Maurer (A)

From the Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Fotis Kotasidis (F)

GE Healthcare, Waukesha, WI.

Ansgar Deibel (A)

Clinic for Gastroenterology and Hepatology and Swiss HPB and Transplant Center, University Hospital Zurich, University of Zurich, Zurich.

Martin W Huellner (MW)

From the Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH